Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal CancerAlan P. Venook, Charles D. Blanke, Bert H. O’Neil et al.|JAMA|2017Cited by 891
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)Hedy L. Kindler, Richard M. Goldberg, Donna Niedzwiecki et al.|Journal of Clinical Oncology|2010Cited by 840
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate dataUlrich Ronellenfitsch, Katrin Jensen, Matthias Schwarzbach et al.|European Journal of Cancer|2013Cited by 169
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical TrialBert H. O’Neil, Richard M. Goldberg, Monica M. Bertagnolli et al.|UNC Libraries|2020Cited by 96